Live Feeds
● LIVE Updated 1h ago · 14 sources tracked

Men battling baldness may soon have a new pill to turn to

An experimental oral medication, VDPHL01, has shown significant hair growth in men with pattern baldness in clinical trials. The pill, developed by Veradermics, was tested on 536 men with mild-to-moderate hair loss and resulted in hair regrowth in 85% of participants. This could be the first new treatment for baldness in nearly 30 years.

🎙️

Listen to Live Briefing

Real-time synthesized voice briefing · Live Feeds Desk

⏱ ~2 min
Speed:
RSS Source map (14)
⚡ Key Developments & Real-Time Context
Text size:
  • ✓ Veradermics' oral hair-loss drug, VDPHL01, showed significant hair growth in a late-stage study.
  • ✓ The VDPHL01 pill was tested on 536 men with mild-to-moderate pattern hair loss.
  • ✓ The experimental treatment resulted in hair regrowth in 85% of men.
🛡️ Source Corroboration: 14 independent reporting domains (85% confidence) ⏱ Read time: ~2 min

What changed

Veradermics' VDPHL01 pill has completed a successful Phase 3 clinical trial, bringing it closer to FDA approval.

Live updates

  1. New pill for baldness shows promise in clinical trials

    An experimental oral medication, VDPHL01, has shown significant hair growth in men with pattern baldness in clinical trials. The pill, developed by Veradermics, was tested on 536 men with mild-to-moderate hair loss and resulted in hair regrowth in 85% of participants. This could be the first new treatment for baldness in nearly 30 years.

    Why it matters

    Male pattern baldness affects millions of men worldwide, and current treatments have limited effectiveness. The last approved treatment for baldness was minoxidil, which was introduced nearly three decades ago. A new pill could provide a more convenient and effective solution for men experiencing hair loss.

    What is confirmed

    • Veradermics' oral hair-loss drug, VDPHL01, showed significant hair growth in a late-stage study.
    • The VDPHL01 pill was tested on 536 men with mild-to-moderate pattern hair loss.
    • The experimental treatment resulted in hair regrowth in 85% of men.

    Still unconfirmed

    • The FDA has not yet approved the VDPHL01 pill for public use.

    What to watch next

    • FDA approval of VDPHL01 pill
    • Results of additional clinical trials
    • Availability of the pill on the market
    Sources used for this update (15)
    1. nypost.com — New York Post – Breaking News, Top Headlines, Photos & Videos
    2. New York Post — Men battling baldness may soon have a new pill to turn to
    3. Reuters — Veradermics' oral hair-loss drug shown to boost hair growth in late-stage study
    4. Clinical Trials Arena — Veradermics’ stock up on male hair loss trial success
    5. The Motley Fool — Why This Hair Restoration Biotech's Shares Are Soaring
    6. The Pharmaletter — The week in pharma: action, reaction and insight – week to October 23, 2026
    7. www.newsbreak.com — Cathie Wood Predicts Oil Crashing to $30-$35 a Barrel as EVs Take Over Transportation: Says Demand Is 'Peaking’
    8. nypost.com — Men battling baldness may soon have a new pill to turn to
    9. mymedicineadvisor.com — Balding Treatment 2026: New Drug Outperforms Minoxidil
    10. www.vice.com — Scientists Tested an Experimental Baldness Pill on 536 Men ...
    11. www.chemdiv.com — A New Hair Loss Pill Moves Closer To FDA Approval After ...
    12. article.wn.com — A New Hair Loss Pill Moves Closer To FDA Approval After A ...
    confidence 85%
📊

Community Sentiment: How do you assess this situation?

Voice your perspective · Real-time aggregated sentiment from the Live Feeds community